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Abstract 
Background: Migraine is a complex neurological disorder that is characterised by debilitating 
headache and temporary neurological disturbances. Investigations into migraine genetics have also 
shown that male probands have a higher proportion of affected first degree relatives and migraine has a 
female preponderance of 3:1. These findings collectively indicate that an X-linked dominant form of 
inheritance may be playing a role in migraine.  
 
Methods: We have previously implicated the Xq24-28 locus in migraine using 2 independent 
multigenerational Australian pedigrees that demonstrated excess allele sharing at the Xq24, Xq27 and 
Xq28 loci. Here, we expand this work to investigate a further 6 independent migraine pedigrees using 
11 microsatellite markers spanning the Xq27-28 region.  Furthermore, 11 candidate genes are 
investigated in an Australian case-control cohort consisting of 500 cases and 500 controls.  
 
Results: Microsatellite analysis showed evidence of excess allele sharing to the Xq27 marker 
DXS8043 (LOD* 1.38 p=0.005) in MF879 whilst a second independent pedigree showed excess allele 
sharing to DXS8061 at Xq28 (LOD* 1.5 p = 0.004). Furthermore, analysis of these key markers in a 
case control cohort showed significant association to migraine in females at the DXS8043 marker (T1 
P=0.009) and association with MO at DXS8061 (T1 P=0.05). Further analysis of 11 key genes across 
these regions showed significant association of a 3 marker risk haplotype in the NSDHL gene at Xq28 
(P=0.0082).  
 
Conclusion: The results of this study, combined with previous evidence supporting an X-linked mode 
of inheritance suggest that susceptibility loci influencing migraine exist independently on Xq27 and 
Xq28 and SNP haplotype analyses indicate the Xq28 causative factor is relatively common in the 
general population. The NSDHL and CNGA2 genes should also be further investigated to elucidate 
their functional implications in this disorder.  
  
 
Keywords: Migraine, MA, MO, X-linked 
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Introduction 
 
Migraine is a common episodic disorder displaying a complex aetiology which is often inherited in 
families. The disorder affects approximately 18% of adult females and 6% of adult males globally 
[1,2]. Migraine is characterised by recurrent headache and neurological disturbances such as 
photophobia and phonophobia. Numerous studies have demonstrated the genetic contribution to 
migraine through pedigree and twin studies with heritability estimates ranging between 34 and 57% 
[3].  
 
Genetic studies have identified three ion channel genes that independently cause the rare migraine 
subtype Familial Hemiplegic Migraine (FHM) [4-6]. However, identification of genes contributing to 
the common forms of migraine; Migraine with (MA) or without (MO) Aura, have been more difficult. 
Genes that have been implicated in MA and/or MO include hormone receptors (Estrogen [7] and 
Progesterone [8]), serotonin genes [9-11], Dopamine Beta Hydroxylase [12,13] and the KCNK18 gene 
encoding the TRESK potassium channel [14] among others. Despite these efforts by our group and 
others, it is still unknown how many genes may be interacting and contributing to common migraine 
pathogenesis. The focus in present genetic research largely centres on neurological, vascular or 
hormonal genes based on the current understanding of migraine pathophysiology.  
 
Linkage studies have also been used to identify a number of migraine susceptibility loci on various 
chromosomes. Results from our laboratory have implicated 1q31 [15]; 3qter, 18p11 [16]; 19p13 [17] 
and the Xq24-28 locus [18,19] in Australian migraine pedigrees. Others have also identified 2 
independent loci on chromosomes 4; 4q21 using Icelandic pedigrees [20] and 4q24 in Finnish 
pedigrees [21]; as well as 5q21 using studies of Australian twins [22]; 6p12.2-21.1 in a Swedish 
pedigree [23] and 15q11-q13 [24]. Susceptibility loci have also been identified on 10q22-23 [25,26,22], 
18q12 [25,26,20] and Xp22 [26,27] using traditional migraine classification methods as well as trait 
component analysis or latent class analysis. However, the majority of these susceptibility loci have not 
been confirmed in independent populations and many are yet to have susceptibility genes identified 
within them. This lack of consensus in identification of susceptibility loci and genes highlights the 
likely heterogeneity of this disorder.   
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Due to the genetic heterogeneity the mode of transmission of migraine remains largely unclear. The 
biased preponderance of migraine in women, as well as studies that demonstrate that a high proportion 
of affected males have a greater number of affected first degree relatives [28] suggests an X-linked 
dominant form of migraine inheritance. Families transmitting migraine through this mode of 
inheritance would show father to daughter transmission and an absence of father to son transmission. 
Therefore an excess of affected females is likely to be observed within these families.  
 
The X chromosome has been previously identified by our laboratory as potentially harbouring a 
susceptibility locus at Xq24-28 [18,17]. Studies of two Australian pedigrees identified three specific 
loci with excess allele sharing in the region. The first was at Xq24 between markers DXS1001 and 
DXS1206, a second at Xq27 between markers DXS984-DXS1123, and the third at Xq28 between 
marker DXS8091 and XqTer. The Xq24 locus contains the candidate gene GRIA3 which has been 
investigated and results described elsewhere [29]. In this study we sought to further investigate the 
Xq27 and Xq28 locus through studies of six new independent Australian migraine pedigrees as well as 
candidate gene studies in an Australian case control cohort.  
 
Materials and Methods:  
Pedigree Study 
Pedigree Collection and Phenotyping 
This study examined 8 Australian Caucasian pedigrees, six new pedigrees designated MF6, MF47, 
MF55, MF541, MF878 and MF879, as well as the previously reported pedigrees MF7 and MF14 
[18,19]. These pedigrees include 161 individuals for whom DNA was available. Ethical clearance was 
granted prior to the commencement of the study by the Griffith University Human Research Ethics 
Committee. All participants signed informed consent statements prior to inclusion in the study and 
were interviewed by a clinical neurologist.  Individuals were diagnosed for migraine (MA or MO) 
according to International Headache Society (IHS) criteria [30]. A questionnaire was used to obtain 
specific information from study participants on a number of relevant factors including age of onset, 
frequency, duration, associated symptoms, medication response and triggers in accordance with IHS 
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guidelines. A total of 96 individuals were classified as affected. Venous blood was collected from 
participants and DNA was isolated from lymphocytes using a standard salting out procedure [31]. 
 
Pedigree Genotyping 
Eleven dinucleotide microsatellite markers were tested in this study. Nine of the 11 markers were 
examined in the initial study to identify this locus and were therefore repeated in the new pedigrees for 
consistency. The additional 2 markers, DXS8043 and DXS1073, were used to aid in finemapping the 
identified region.   
 
Marker order and positions were acquired from Duffy’s interpolated Rutgers Map [32] with markers 
spaced approximately 5.5cM apart spanning a 66cM region. Marker names and cumulative positions in 
Kosambi centimorgans (cM) are:  
 
DXS1206 (0.0) - DXS984 (13.8) - DXS8106 (23.39) - DXS8043 (28.6) - DXS297 (32.8) - DXS8091 
(35.54) - DXS1123 (37.22) - DXS8061 (47.68) - DXS15 (48.24) - DXS1073 (51.09) - DXS1108 
(51.57) 
  
Microsatellites were amplified using standard PCR with 5’ labelled forward primers where the labels 
were either FAM, PET, NED or VIC. Primer sequences are given in Online Resource 1 and PCR 
conditions are available on request. Where possible, due to overlapping fragment size and limited 
labels, PCR products were multiplexed before sizing by capillary electrophoresis using the Applied 
Biosystems ABI 3130 Genetic Analyser. Genotypes were called using the Applied Biosystems 
GENEMAPPER® software Version 4.0. 
  
Statistical Analysis of Pedigrees 
Prior to statistical analysis genotype data was screened for mendelian and relationship inconsistencies 
using Pedcheck [33]. Error checking was also performed in the MINX program and unlikely genotypes 
were resolved or removed. The Kong and Cox GENEHUNTER PLUS (X-Linkage version 1.2) 
statistical software [34] was used to carry out non-parametric multipoint linkage analysis of these 
pedigrees using the Sall scoring function. Non-parametric analysis was chosen to overcome difficulties 
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in defining unknown inheritance parameters. The Sall statistic was chosen as it measures IBD allele 
sharing among all individuals simultaneously rather then pairs of affected relatives therefore assigning 
a higher score as more individuals share the same allele by descent. The LOD* scores were determined 
implementing the exponential model. Previously reported pedigrees MF7 and MF14 were reanalysed 
with additional makers and an updated marker map. Linkage peaks yielding LOD* scores ≥ 1 are 
suggestive of linkage for X chromosome markers whilst LOD* scores ≥ 2 indicate significant linkage. 
LOD scores were converted to P values using the ConvertingLODtoPvalue spreadsheet [35]. 
Haplotypes were determined from genotype and pedigree information using the X-linked version of 
Merlin, Minx [36] and diagrams were created using the Haplopainter program [37] .  
 
Association study  
Population Collection and Phenotyping 
The study protocol was approved by Griffith University’s ethics committee for experimentation on 
humans. All individuals were of Caucasian origin and gave informed consent before participating in the 
research. Migraineurs were diagnosed as having either MA or MO, based strictly on criteria specified 
by the IHS. All individuals were grouped together and phenotyped as being affected with typical 
migraine, as well as being diagnosed separately as MA or MO subgroups. The case-control study 
cohort was comprised of 500 migraineurs (360 MA/140 MO; 393 Female/107 Male) and 500 unrelated 
control individuals. To minimise potential bias from population stratification, the control group was 
matched for sex, age (+/- 5 years) and ethnicity to the migraineurs.  
 
Microsatellite Markers 
Two key microsatellite markers identified in the Xq27 (DXS8043) and Xq28 (DXS8061) loci were 
genotyped in the association study population to determine if the association was pedigree specific or 
could translate to the general population. Genotyping was carried out using the same process described 
for the pedigree study.  
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Candidate Gene Studies 
A gene map of the Xq27 and Xq28 regions were obtained from NCBI (Homo sapiens Genome Build 
37.2) and public databases (eg. Pubmed) were interrogated for functional gene information in order to 
select a final list of 2 genes in the Xq27 locus and 10 genes in the Xq28 locus (Online Resource 2).  
 
Hapmap CEU data was downloaded for each candidate gene and the tagger algorithm in Haploview 
[38] was used to identify 36 SNPs across 11 of the 12 genes that captured the maximum degree of 
variation attainable while being constrained by multiplexing genotyping techniques. Of the 
polymorphisms genotyped across the 2 regions, 1 is an insertion/deletion polymorphism in GPR50 
amplified using standard PCR with 5’ FAM labelled forward primer (Online Resource 1). PCR 
conditions are available on request. Genotypes were determined by capillary electrophoresis using the 
Applied Biosystems ABI 3130 Genetic Analyser. Genotypes were called using the Applied Biosystems 
GENEMAPPER® software Version 4.0. The remaining 35 SNPs were genotyped at Australian 
Genome Research Facility (AGRF) using the Sequenom MassArray on an Autoflex Spectrometer and 
iPLEX GOLD chemistry.  
 
Statistical Analysis of case-control cohort 
Microsatellites were tested for association using the CLUMP analysis program [39]. To detect 
association between the SNP markers and migraine, we performed chi-square (χ²) analysis to test for 
significant differences in allele and genotype frequencies (females only for associated SNPs) in case 
versus control results. χ² provides the likelihood of a deviation in the distribution of the same attributes 
in different classes (e.g. allelic frequencies in controls versus affected subjects). Hardy-Weinberg 
Equilibrium (HWE) for females control genotypes were also calculated using PLINK [40]. For the 
candidate gene study locus-specific correction set the significance level at 0.008 for Xq27 and 0.001 
for Xq28. Haplotype frequency estimates and analysis of the haplotype block consisting of markers 
rs5970389, rs6653488 and rs2071256 in the MO and control cohorts were performed using Haploview 
[41].  
 
Results:  
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The current study presents an analysis of the previously identified migraine susceptibility locus, Xq27 - 
Xq28, using six new multigenerational Australian migraine pedigrees. In addition two of these markers 
were also analysed in a case-control migraine cohort to investigate this signal in a general migraine 
population. Finally, this study also interrogates a number of candidate genes within the identified 
susceptibility region.  
 
Pedigree analysis 
We reported previously the identification of a migraine susceptibility locus on chromosome Xq24-28 
[18, 19]. Significant excess allele sharing was indicated by nonparametric linkage analysis producing 
maximum global LOD* scores of 2.31 between DXS8106 and DXS091; and LOD* 2.18 at DXS8061.  
 
For the present study, we included new and combined analysis of the two previously published 
pedigrees and six new migraine pedigrees confirming the excess allele-sharing across this region. 
Analysis was performed in the pedigrees with individuals classed as affected, unaffected or unknown, 
combining the MA and MO phenotypes as a spectrum of the migraine disorder. An analysis was also 
undertaken with individuals classed as either unknown or affected in case migraine had not manifested 
in the individual due to a lack of environmental triggers. However, this analysis did not significantly 
vary the outcome and therefore results are not included.   
 
Analysis of the pedigrees verified and refined the previously localised susceptibility regions. Migraine 
pedigrees MF6, MF55, MF541 and MF878 did not show evidence of excess allele sharing to the Xq27-
28 region (data not shown). However, analysis of the remaining migraine families confirmed the 
previous observation at Xq27 and Xq28 (Figure 1). At the Xq27 loci maximum LOD* scores of 1.32 
(P=0.0068), 1.35 (P=0.0063) and 1.38 (P=0.0058) were identified for MF7, MF14 and MF879 
respectively. Similarly at the Xq28 locus maximum LOD* scores of 1.33-1.50 spanned the locus from 
DXS8061 to the final marker DXS1108 in MF7, MF14 and MF47 (Figure 1).  
 
An initial global scan of all migraine families included in the study was suggestive of linkage across 
Xq27 and Xq28 with maximum LOD* scores peaking at 1.63 (P=0.003) at DXS8043 (Figure 1). To 
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determine the effect the 4 families that did not show excess allele sharing to the Xq27 or Xq28 region 
were having on this result a further analysis was conducted removing these families (Figure 1).  
 
Previous analysis of MF7 and MF14 has also shown evidence to support genetic heterogeneity of the 
disorder in these families [18] potentially suggesting that 2 independent loci exist in this region. 
Analysis of the new migraine families supports this theory as the individual analysis of MF879 only 
shows excess allele sharing at Xq27 and conversely MF47 only shows excess allele sharing at Xq28.  
A global analysis was therefore performed on each region using only those pedigrees that implicated 
the respective loci in order to refine the linkage regions for further analysis. This analysis revealed a 
maximum global LOD score of 3.69 (P=1.88x10-5) between markers DXS8043 and DXS297 at Xq27 
for the combined analysis of MF7, MF14 and MF879. At Xq28 the combined analysis of MF7, MF14 
and MF47 showed a LOD* of 3.65 (P=2.07X10-5) at DXS8061. 
 
Haplotype analysis confirmed a narrowed Xq27 region from the previous study through critical 
recombination events in the new MF879 pedigree. Individuals IV:4 and IV:5 in MF879 show 
recombination at DXS8043xDXS297, the markers that bound the Xq27 locus, suggesting that a 
susceptibility candidate in this region is between these markers (Figure 2). While the new pedigree 
MF47 was also shown to display excess allele sharing to the Xq28 region, haplotype analysis did not 
narrow the region that was identified previously [18].  
 
The Xq27 region implicated by these studies are bordered by markers DXS8043 and DXS297 
translating to at most a 2.4Mb region. Similarly the Xq28 region is limited by DXS8061 to the Xqter 
equating to an approximate 4Mb region.  
 
Investigation of key microsatellite markers in a case-control cohort 
In order to test if the signals identified at the Xq27 and Xq28 loci were pedigree specific or translated 
to the general population two key microsatellite markers in the regions were genotyped in an Australian 
migraine case control cohort. The markers DXS8043 and DXS8061 (Xq27 and Xq28 respectively) 
showed evidence of association in the tested female population (P=0.009 and P=0.07 respectively). 
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While DXS8043 appears not to be specific to a particular migraine subtype, DXS8061 is clearly 
associated with the MO class (P=0.05, Table 1).  
 
A SNP in close proximity to each marker was also genotyped in this population to verify the 
association seen by the microsatellites. rs5920369 located 720bp upstream to DXS8043 confirmed the 
association to the female population (genotype P=0.01). While rs6653488, 2.8Kb from DXS8061 also 
showed association to females (P=0.02). 
 
Xq27 Candidate Gene Study 
Interrogation of public databases for gene annotations in the ~2.4Mb Xq27 loci bordered by markers 
DXS8043 and DXS297 identified very few known genes. Consequently only 2 candidate genes were 
selected for further analysis, SLITRK2 and CXorf1 (see Online Resource 2). Four SNPs were identified 
for analysis across these 2 genes. All SNPs were in HWE however none showed association.  
 
Xq28 Candidate Gene Study 
In contrast to the Xq27 locus the Xq28 region harbours numerous potential candidate genes. In this 
region 29 SNPs were chosen across 9 candidate genes. These genes were selected based on known or 
implied functional roles in hormonal, vascular or neurological systems (see Online Resource 2).  
 
One SNP was found to be in HWD (P<0.001) and was not used for further studies. Chi square analysis 
identified a SNP in CNGA2 with positive association, P=0.048, which was also stronger in females 
(genotype P=0.0038) when analysed by gender, however this did not remain significant after 
corrections. No other SNPs were associated in the entire cohort or when stratified by gender.  
 
However to further investigate the association to MO observed at the microsatellite marker DXS8061, 
the SNPs around this marker were also tested for association to this migraine class. This analysis 
identified 3 SNPs around the DXS8061 marker that independently showed a trend towards association 
with MO (P≤0.07). Haplotype analysis of this series of SNPs revealed a 3 marker risk haplotype at 
rs5970389, rs6653488 and rs2071256 (P=0.0082, OR=1.53 CI=1.11-2.11) in the NSDHL gene (Table 
2). 
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Discussion:  
The genetic basis of common migraine, MA and MO is yet to be deciphered. To date, loci on many 
chromosomes as well as a number of genes have been implicated yet we still lack replication studies to 
validate these findings. Furthermore, the current understanding of migraine pathophysiology is 
fragmented with the vascular, hormonal and neural systems all thought to play a role.  
 
The unequal sex distribution in the general population strongly implicates a hormonal influence on 
migraine pathophysiology. Epidemiological data supports this as prevalence significantly increases in 
females at the time of puberty and decreases around the time of menopause [42]. Furthermore, 7-8% of 
migraineurs experience the ICHD classified, Pure Menstrual Migraine, where MO occurs only on day 
1±2 days of menstruation in every 2 of 3 cycles. While it is not specifically known how hormones 
contribute to migraine it has been demonstrated that some hormones, particularly estrogen, interact 
with other genes that have been implicated in migraine such as serotonin receptors and calcitonin gene 
related peptide (CGRP) [43]. However to date studies of these genes have failed to provide conclusive 
evidence that hormones are the sole factor causing the female preponderance of migraine. It is 
therefore a distinct possibility that genes on the X chromosome may also be contributing to 
susceptibility to the disorder.  
 
In this study we have expanded on previous work to narrow known susceptibility regions on the X 
chromosome in order to reduce the number of potential candidate genes for testing in common 
migraine. The initial scan by this laboratory was performed using 28 markers across the X chromosome 
in two Australian pedigrees. Results demonstrated significant NPL scores at markers DXS1001 (Xq24) 
and DXS1123 (Xq28) [19]. A follow-up study of these two pedigrees focused on the Xq region using 
16 markers that identified three distinct loci. The first was at Xq24 spanning from markers DXS1001 to 
DXS1206 the second was at Xq27 from markers DXS984 to DXS1123 and the third at Xq28 from 
DXS8091 to XqTer [18]. 
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Here, we expand on these findings in 6 new Australian migraine pedigrees. In the initial study the 
Xq27 locus was identified as spanning an 11Mb region from markers DXS984 to DXS1123. Through 
genotyping of an additional marker in this region (DXS8043) we have reduced the locus shared by 3 
pedigrees to a 2.4Mb region, assuming that all pedigrees are segregating to the same susceptibility 
gene. In addition the genotyping of additional migraine pedigrees has identified 2 previously 
unreported pedigrees that segregate to the 2 susceptibility regions strongly confirming a role for the X 
chromosomes in migraine.   
 
This study also provides further evidence to indicate that the identified regions can be considered two 
separate loci, independently harbouring susceptibility variants. While MF7 and MF14 show excess 
allele sharing at both regions MF879 only associated with the Xq27 locus, similarly MF47 only 
associated with the Xq28 locus. In addition, the Xq27 locus has now been identified in three separate 
studies. Oedegaard and colleagues [44] conducted a genome wide linkage study of bi-polar disorder 
and co-morbid migraine using pedigrees derived from the National Institute of Mental Health (NIMH) 
Genetics Initiative for Bipolar Disorder. They identified a linkage peak with a LOD score of 1.6 
(P=0.003) in the Xq27 region (marker DXS9908 approx 1Mb from DXS8043) that segregated with 
only the migraine and not the bipolar phenotype.  
 
Our finding that the key markers identifying the X chromosome susceptibility regions are also 
associated in a case-control population provides evidence that these loci are not pedigree specific and 
may be contributing to migraine in the general population. This result provides the impetus to identify 
the causative variants through candidate gene studies.  
 
The Xq27 loci appears to be a particularly ‘gene poor’ region. To date few annotations in this region 
are available on public databases. Consequently only 2 genes (SLITRK2 and CXorf1) were examined in 
the region with neither showing association.  
 
In contrast the Xq28 region contains numerous potential candidate genes such as the neurotransmitter 
genes SLC6A8, GABRE, GABR3 and GABRQ and ion channel genes CLIC2 and CNGA2. In particular 
GABRA3 was of interest due to the plethora of evidence implicating a role for glutamate in migraine 
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particularly in increasing susceptibility to cortical spreading depression [45,46]. The GABRE and 
GABRQ genes located in the Xq28 region were not selected as these have been analysed and reported 
previously as showing no association to migraine in our Australian populations [47]. The ATP2B3 gene 
was also selected as this gene belongs to the ATPase family similar to the FHM2 gene ATP1A2, and 
furthermore, ATP2B3 is thought to play a role in calcium homeostasis as does the FHM1 gene 
CACNA1A. Other genes selected for this study are known ion channels thought to be involved in 
neurological processes. The ion channel genes were of particular interest as it has been established that 
FHM can be caused by independent mutations in three different ion channels. Additionally ion 
channels may play a role in neuronal excitability, potentially contributing to the precipitation of 
migraine attack.  
 
While this study did not strongly implicate any of the tested genes in migraine, suggestive evidence of 
a 3 marker haplotype in the MO subtype may be seen in the NSDHL gene. This gene is involved in the 
synthesis of cholesterol and loss-of-function mutations are typically associated with CHILD syndrome, 
a severe disorder that is lethal in males.  However numerous studies have linked CVD with migraine 
and some studies suggest an influence of cholesterol levels on both disorders [48-50]. Nonetheless the 
results of this study nominally suggest an involvement of NSDHL in migraine, therefore if this gene is 
involved, significant further research into the functional implications of genetic variants in this gene 
need to be investigated.  
 
Conclusion: 
The unequal sex distribution of migraine is a unique facet of this disorder that may be explained by 
hormones and/or underlying genetic variations on the X chromosome that potentially cause migraine 
predisposition. The polygenic nature of migraine suggests that an interaction of both these mechanisms 
is also a possibility. The results of this study suggest that 2 distinct susceptibility variants may exist at 
Xq27 (marked by DXS8043 – DXS297) and Xq28 (DXS8061 – XqTer) and that these susceptibility 
loci may extend to association in the general population. Further studies are warranted to identify the 
pathological relevance of these loci to migraine aetiology.  
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Table 1: Microsatellite analysis in case-control cohort 
Marker Position Locus CLUMP analysis P value 
Cases v 
Controls 
MA v 
Controls 
MO v 
Controls 
Male v 
Controls 
Female v 
Controls 
DXS8043 
 
143836250 
 
Xq27 
 0.014 0.019 0.012 0.7 0.009 
DXS8061 151772260 Xq28 0.25 0.5 0.05 0.61 0.07 
 
Table 2: Xq28 MO Risk Haplotype rs5970389, rs6653488 and rs2071256 
Haplotype Freq (MO) Freq (Cases) χ2 P OR 95% CI 
TTC 0.689 0.591 6.997 0.0082 1.53 1.11-2.11 
CCG 0.148 0.229 6.687 0.0097 0.58 0.38-0.88 
CTG 0.112 0.12 0.0105 0.7464 0.92 0.57-1.48 
TTG 0.035 0.051 0.867 0.3518 0.69 0.31-1.51 
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